The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry.

Cell Cycle
Fionnuala MorrishDavid Hockenbery

Abstract

The c-myc proto-oncogene is rapidly activated by serum and regulates genes involved in metabolism and cell cycle progression. This gene is thereby uniquely poised to coordinate both the metabolic and cell cycle regulatory events required for cell cycle entry. However, this function of Myc has not been evaluated. Using a rat fibroblast model of isogenic cell lines, myc(-/-), myc(+/-), myc(+/+) and myc(-/-) cells with an inducible c-myc transgene (mycER), we show that the Myc protein programs cells to utilize both oxidative phosphorylation and glycolysis to drive cell cycle progression. We demonstrate this coordinate regulation of metabolic networks is essential, as specific inhibitors of these pathways block Myc-induced proliferation. Metabolic events temporally correlated with cell cycle entry include increased oxygen consumption, mitochondrial function, pyruvate and lactate production, and ATP generation. Treatment of normal cells with inhibitors of oxidative phosphorylation recapitulates the myc(-/-) phenotype, resulting in impaired cell cycle entry and reduced metabolism. Combined with a kinetic expression profiling analysis of genes linked to mitochondrial function, our study indicates that Myc's ability to coordinately reg...Continue Reading

Citations

Aug 13, 2013·Trends in Biochemical Sciences·Kee Chung Low, Vinay Tergaonkar
Dec 6, 2011·Cell Death and Differentiation·E C FerberA Schulze
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·David R WiseCraig B Thompson
Aug 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·James W ClendeningLinda Z Penn
Dec 19, 2009·The Journal of Biological Chemistry·Yongjun FanWei-Xing Zong
Oct 17, 2008·Genes & Development·Martin Eilers, Robert N Eisenman
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chi V DangPing Gao
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David A MankoffJennifer M Specht
Oct 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Donald M MillerKara Sedoris
Nov 16, 2011·Molecular Cancer Therapeutics·Kara C SedorisDonald M Miller
Jan 22, 2013·Biology Open·Kaveh DaneshvarJulie M Goodliffe
Nov 17, 2009·PloS One·Chin-Hsing LinRobert N Eisenman
May 26, 2012·PloS One·J Anthony GravesEdward V Prochownik
Nov 15, 2011·Annual Review of Pathology·Federica SotgiaMichael P Lisanti
Jun 5, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hanna ZirathMarie Arsenian Henriksson
Oct 11, 2015·Seminars in Cancer Biology·Matthew D HirscheyUNKNOWN Target Validation Team
Dec 3, 2014·Current Opinion in Biotechnology·Alessandro Carrer, Kathryn E Wellen
Jan 30, 2013·Pharmacology & Therapeutics·Santiago Diaz-MoralliMarta Cascante
Aug 18, 2012·Metabolic Engineering·Taylor A MurphyJamey D Young
Jan 4, 2012·Pharmacology & Therapeutics·Teresa W-M FanAndrew N Lane
Jan 9, 2013·Biotechnology and Bioengineering·Taylor A Murphy, Jamey D Young
Jun 17, 2010·IUBMB Life·Laura FormentiniJosé M Cuezva
Jun 15, 2010·Environmental and Molecular Mutagenesis·Michelle Barbi de MouraBennett Van Houten
Apr 12, 2014·Molecular Oncology·Shiri DovratRina Rosin-Arbesfeld
Apr 14, 2016·Progress in Lipid Research·Sean P ArlauckasE James Delikatny
Apr 9, 2013·Biochimica Et Biophysica Acta·Giorgia ZadraMassimo Loda
Jul 28, 2012·The Biochemical Journal·Salvador MoncadaSergio L Colombo
Oct 12, 2010·Biochimica Et Biophysica Acta·Richard C Scarpulla
Jul 21, 2015·Nature Cell Biology·Huayang LiuGustavo Leone
May 4, 2011·Molecular Oncology·Siver Andreas MoestueIngrid Susann Gribbestad
May 8, 2009·Biochimica Et Biophysica Acta·José M CuezvaMaría Sánchez-Aragó
Dec 15, 2010·Cell Cycle·Vivian Chen, Emma Shtivelman
Jan 1, 2013·Computational and Structural Biotechnology Journal·Emily R Roberts, Kelly Jean Thomas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.